APA (7th ed.) Citation

Luo, R., Yu, M., Kang, K., Zhang, Y., Xue, J., & Lu, Y. (2025). SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis. Zenodo.

Chicago Style (17th ed.) Citation

Luo, Ren, Min Yu, Kai Kang, Yufeng Zhang, Jianxin Xue, and You Lu. SBRT Embedded in Low-dose RT Plus αPD-1 (immuno-EclipseRT, IERT) Elicits CD8+ T Cell Immunity Against Bulky Tumors via an IFN-I/NK/DC Axis. Zenodo, 2025.

MLA (9th ed.) Citation

Luo, Ren, et al. SBRT Embedded in Low-dose RT Plus αPD-1 (immuno-EclipseRT, IERT) Elicits CD8+ T Cell Immunity Against Bulky Tumors via an IFN-I/NK/DC Axis. Zenodo, 2025.